Ardigen is harnessing advanced AI methods for novel precision medicine. The company accelerates therapy development by designing immunity, decoding microbiome, analyzing biomedical images and providing digital drug discovery services. Ardigen’s team is rooted in biology and holds deep expertise in bioinformatics, machine learning, and software engineering. The company’s in-house datasets, together with advanced AI platforms, empower the development of effective precision therapies.
The unique strength of our team is the capability to provide a comprehensive solution to your problem. We effectively combine efforts of biologists, bioinformaticians, data scientists and software engineers to deliver value to all our collaborators.
Science projects providing reproducible research and software tools while staying lean and dynamic. We make bioinformatics workflows and software with human readable code, as well as machine learning models that "understand" biological data and provide cutting edge solutions and products for
At Atreca, Ardigen has established themselves as a comprehensive service providing a multi-disciplined team that manages all aspects of our Informatics needs. We have been impressed with their flexibility to grow teams and add new specializations on-demand at a reasonable cost.
“Ardigen hit a grand slam for us! Their expertise and mastery of microbiome data mining and predictive analytics found important and unique biomarkers in our data where others had failed. The team was amazing and I would work with them again in a heartbeat.”
“Ardigen has been a great bioinformatics partner for Acrigen Biosciences. They were able to develop a custom bioinformatics workflow and wrap it in a web application, allowing easy access for our scientists.”
“CVC is excited to be working with Ardigen who are at the forefront of T-cell epitope design. The collaboration gives us the best chance of our product inducing an effective T-cell response against SARS-Cov-2.”
“The PRISM pipeline has dramatically improved our discovery efforts and uncovered new unexpected lead candidates. In addition, the deployment on cloud computing resources has allowed our discovery team to explore possibilities that would be untenable under traditional settings.”
“Working with Ardigen has enabled us to apply precision bioinformatics and machine learning to our most pressing problems.”
“We at Targovax have been impressed and delighted with Ardigen’s expertise, professional attitude, attention to details and flexibility. We also highly value their individual approach when working with clients, and last but not least, their result delivery is on time. Generated results represent a key component of our clinical pipeline readouts.”
“Our strategic partnership with Ardigen has enabled us to not only keep pace with, but vastly exceed the expectations of our diverse and rapidly expanding user base of over 40 major pharmas and biotechs.”
“We’re extremely happy with Ardigen’s level of responsiveness, attention to details and overall technical insight.”
“Ardigen’s deep understanding of the complexities of molecular biology work flows and data has made them our partner of choice.”
“I’ve been really impressed with their expertise and communication skills. When we give them an analysis task, they go beyond what we’ve asked for and suggest and test new methods.”
Biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
Biotechnology company developing novel immunotherapies.
Biopharmaceutical company focused on developing novel treatments for neurobehavioral disorders.
One of the biggest hospitals on the East Coast of the US
The third-oldest medical school in the United States, the graduate of Harvard University.
Biopharma company focused on novel approach to therapeutic discovery.
“The feedback I have from the Clinical team is that your resources are doing an excellent job.”
Company specializing in treatment of various cardiological and rheumatological conditions.
Leading science and technology company in healthcare, life science and performance materials.
Company focusing on novel treatments of metabolism, immunology, oncology and CNS related diseases.
The largest institution of higher learning in Poland’s northern region of Pomerania.
Originated in 1611 and officially opened in 1919, has been frequently listed as a top three university in the country.
A company developing analytic platforms to analyze DNA and other genome-related peptides and proteins.
To join us means to participate in our fight against cancer. Depending on your specialization, you may analyze multi-omics data, design and implement bioinformatics and AI solutions towards Precision Medicine. You will have an important impact on innovations in cancer diagnostics and treatments, one of the biggest challenges of contemporary medicine. Find out who we are currently looking for and how exactly you may grow with us!